Intravenous Immunoglobulin for Treatment of Recurrent Pregnancy Loss

American Journal of Reproductive Immunology

Volumn 34, Issue 6, 1995, Pages 333-337

  COULAM, CAROLYN B ^a   KRYSA, LOIS ^a   STERN, J JAROSLAV ^a   BUSTILLO, MARÍA ^a  

^a GENETICS AND IVF INSTITUTE   (United States)

Author keywords

immunotherapy; intravenous immunoglobulin; Recurrent spontaneous abortion

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONCEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNIZATION; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT ABORTION; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOTHERAPY; ODDS RATIO; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES;

EID: 0028834847     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1995.tb00960.x     Document Type: Article

References (29)

1. Unification of immunotherapy protocols
2. Recurrent spontaneous abortion
3. Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells
4. Immunization as therapy for recurrent spontaneous abortion: a review and metaanalysis
5. The use of intravenous immunoglobulin for the treatment of recurrent spontaneous abortion
6. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin
7. IVIg to prevent recurrent spontaneous abortion
8. Intravenous IgG therapy for anticardiolipin syndrome: A case report (abstract)
9. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization
10. Lupus anticoagulant and recurrent fetal loss: Successful treatment with gammaglobulin
11. Repeated fetal losses and the lupus anticoagulant
12. Intravenous gammaglobulin, antiphospholipid antibodies and pregnancy
13. Intravenous immunoglobulin treatment of women with multiple miscarriages
14. Short‐term reproductive prognosis when no cause can be found for recurrent miscarriage
15. Risk factors for spontaneous abortion and its recurrence
16. Reproductive counseling in patients who have had a spontaneous abortion
17. Reproductive outcome in women with recurrent spontaneous abortions of alloimmune and autoimmune causes: preconception versus postconception treatment
18. Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations
19. Quantitation of soluble HLA class I antigen in human albumin and immunoglobulin preparations for intravenous use by solid‐phase immunoassay
20. The effect of chronic exposure to clotting factor concentrates on the immune system
21. Beneficial effect of intravenous gammaglobulin in a patient with complement‐mediated autoimmune thrombocytopenia due to IgM‐antiplatelet antibodies
22. Modulation of mononuclear phagocyte function by intravenous gammaglobulin
23. Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura
24. Hypothetic and established action mechanisms of therapy with immunoglobulin G
25. Interaction of C3 and C3b with immunoglobulin
26. Effect of immunoglobulin substitution on serum immunoglobulin and complement concentration
27. The use and mechanisms of action of intravenous immunoglobulin: An update
28. Ultrasonographic findings of pregnancy losses after treatment for recurrent pregnancy loss: intravenous immunoglobulin versus placebo